IL17A and Alzheimer disease: Experimental evidence demonstrates that neutralization of IL-17 not only rescues Aβ-induced cognitive deficits but also attenuates systemic inflammation, vascular dysfunction, and the prothrombotic state associated with AD, revealing the multifaceted role of this pathway in pathogenesis (75).